Trials / Completed
CompletedNCT00000446
Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
Sertraline Treatment in Comorbid Post-Traumatic Stress Disorder and Alcoholism
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial. All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and 6, 9, and 12 months after study entry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sertraline (Zoloft) |
Timeline
- Completion
- 2000-12-01
- First posted
- 1999-11-03
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000446. Inclusion in this directory is not an endorsement.